November 24, 2020, 15:42


Bristol-Myers Squibb buying Celgene in $74B deal

Bristol-Myers Squibb buying Celgene in $74B deal

Bristol-Myers Squibb is spending $74 billion on fellow drugmaker Celgene in a deal aimed at stocking the combined company’s development pipeline with cancer, immunology and cardiovascular treatments.

Bristol would gain the cancer treatment Revlimid in the cash-and-stock deal announced Thursday, as well as inflammatory disease treatments and several products close to launching.

The combined company will have nine products with more than $1 billion in annual sales. Bristol’s product portfolio already includes Orencia, an injected drug for rheumatoid arthritis, and the cancer treatment Opdivo.

Bristol Chairman and CEO Giovanni Caforio said in a prepared statement that the combination will create a deep product portfolio that drives growth.

It was a hard sell, however, on Wall Street. Shares of Bristol ended Thursday down $6.90, or 13.3 percent, at $45.12, on a day when the Standard & Poor’s 500 lost 2.5 percent. Celgene shares, however, soared $13.79, or 20.7 percent, to $80.43.

Under terms of the deal, shareholders of Celgene Corp., based in Summit, New Jersey, will receive one share of Bristol-Myers Squibb plus $50 in cash for each share they own. They’ll also receive one tradeable contingent value right for each Celgene share, allowing the holder to receive a $9 payment when future regulatory milestones are hit.

The cash-and-stock portion of the deal totals $102.43, based on Wednesday’s closing price of $52.43 for Bristol shares. That represents a premium of nearly 54 percent to Celgene’s closing price of $66.64.

Shareholders of Bristol-Myers Squibb Co., based in New York, would own about 69 percent of the company, with Celgene shareholders owning about 31 percent.

.

Sourse: abcnews.go.com

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *

Weather

Moscow

Today11/23/2020
0℃

Tue
11/24/2020
overcast clouds

  • overcast clouds
  • HI/LO: 1/0
  • Clouds: 99%
  • Wind: 3.06 m/s
  • Wind Direction: WSW
  • Pressure: 1008hPa
  • Humidity: 98%

Wed
11/25/2020
overcast clouds

  • overcast clouds
  • HI/LO: 1/-1
  • Clouds: 98%
  • Wind: 2.54 m/s
  • Wind Direction: NW
  • Pressure: 1016hPa
  • Humidity: 94%

Thu
11/26/2020
moderate rain

  • moderate rain
  • HI/LO: 1/-1
  • Clouds: 95%
  • Wind: 3.76 m/s
  • Wind Direction: S
  • Pressure: 1019hPa
  • Humidity: 95%

Fri
11/27/2020
overcast clouds

  • overcast clouds
  • HI/LO: 2/0
  • Clouds: 100%
  • Wind: 2.18 m/s
  • Wind Direction: WSW
  • Pressure: 1008hPa
  • Humidity: 98%

Sat
11/28/2020
overcast clouds

  • overcast clouds
  • HI/LO: 0/-1
  • Clouds: 97%
  • Wind: 2.91 m/s
  • Wind Direction: NNW
  • Pressure: 1018hPa
  • Humidity: 97%

Sun
11/29/2020
light snow

  • light snow
  • HI/LO: -1/-4
  • Clouds: 100%
  • Wind: 3.42 m/s
  • Wind Direction: NE
  • Pressure: 1027hPa
  • Humidity: 96%

Сторонняя реклама



Статьи
Статьи В
Создание Сайта Кемерово, Создание Дизайна, продвижение Кемерово, Умный дом Кемерово, Спутниковые телефоны Кемерово - Партнёры